Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,518 | 164,158 | 355,968 | N/A | N/A |
| Marketable Securities | 264,055 | 231,436 | 79,672 | N/A | N/A |
| TOTAL | $307,755 | $400,739 | $439,235 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 28,689 | 15,402 | 4,018 | N/A | N/A |
| Investments And Advances | 9,839 | 52,032 | 38,411 | 0 | 0 |
| Intangibles | 172,850 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,036 | 7,873 | 7,499 | 0 | 0 |
| TOTAL | $216,414 | $75,307 | $49,928 | $N/A | $N/A |
| Total Assets | $524,169 | $476,046 | $489,163 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,902 | 866 | 1,096 | 0 | 0 |
| Accrued Expenses | 26,341 | 12,410 | 14,577 | N/A | N/A |
| Other current liabilities | 132,213 | 123,830 | 84,920 | N/A | N/A |
| TOTAL | $160,456 | $137,447 | $100,593 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32,686 | 0 | 38 | 0 | 0 |
| TOTAL | $52,409 | $9,545 | $38 | $N/A | $N/A |
| Total Liabilities | $212,865 | $146,992 | $100,631 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,556 | 90,426 | N/A | N/A | N/A |
| Common Shares | 9 | 8 | 8 | N/A | N/A |
| Retained earnings | -477,204 | -411,246 | -346,281 | N/A | N/A |
| Other shareholders' equity | -849 | -18 | -90 | 0 | 0 |
| TOTAL | $311,304 | $329,054 | $388,532 | $N/A | $N/A |
| Total Liabilities And Equity | $524,169 | $476,046 | $489,163 | $0 | $0 |